Mesut Tığlıoğlu

4PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersOphthalmology and optometry not elsewhere classifiedMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 14, 2021
The outcome of COVID-19 in patients with hematological malignancy.

Pınar Tığlıoğlu, Murat Albayrak, Mesut Tığlıoğlu

|Nov 15, 2021
Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.

Fatma Yılmaz, Murat Albayrak, Pınar Tığlıoğlu

|Aug 23, 2021
Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect.

Mesut Tığlıoğlu, Pınar Tığlıoğlu, Abdulkerim Yıldız

|Apr 13, 2021
Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case.

Hacer Berna Afacan Ozturk, Murat Albayrak, Senem Maral

Pageof 1

Frequent Collaborators

4 joint publications

Hacer Berna Afacan Ozturk

4 joint publications

Merih Reis Aras

3 joint publications

Senem Maral

3 joint publications

Pınar Tığlıoğlu